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 Summary
  Pneumonia remains an important source of morbidity and mortality in transplant recipients. Since 
clinical findings are nonspecific and cultures may be time-consuming, imaging plays an important 
role in establishing the probable etiology of pneumonia. Plain films are used as an initial study. 
However, they have a limited capacity in differentiating the causative factors. HRCT is used as a 
problem-solving tool in patients with unclear plain film findings and/or no response to treatment. 
The main advantage of HRCT is a very detailed depiction of the lung parenchyma. Even though 
HRCT findings are not always specific, there are several sings that are more common in certain 
types of pneumonia. The aim of the article is to present radiological findings suggestive of a 
particular causative microorganism and show how they can narrow the differential diagnosis when 
coupled with clinical data.
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In Poland transplantation of organs is conducted since the 
end of the 1960-ties and within the last 10 years the num-
ber of transplanted organs amounted to approx. 1200 per 
annum [1]. In 2010 there were 1376 transplantations of 
organs including 1306 from the dead donors (970 kidneys, 
212 livers, 79 hearts, 17 lungs, 20 pancreases, 3 forearms) 
and 70 organs of living donors (50 kidneys, and 20 liver 
fragments) [2]. Transplantation means prolongation and 
improvement of life comfort of the ill with the end-stage 
renal disease of internal organs. However, the number of 
patients prone to complications connected with immuno-
suppressive treatment increases every year. Lungs are one 
of the most frequent infection locations among patients 
receiving immunosuppressive treatment [3]. The high-
est morbidity can be observed among patients after lungs 
and heart transplantations. Lower morbidity rate relates 
to the patients after kidney and liver transplantations[3]. 
Pneumonia among patients with defective immunity con-
stitutes a serious problem as it endangers their life and 
mortality rate amounts to 4–10% [4,5].
Plain chest X-ray is one of the first additional tests con-
ducted among transplant recipients with infection 
symptoms[6]. In case of anomaly noticed on the basis of 
X-ray, the treatment starts with empiric antibiotics ther-
apy. The symptoms defined according to the X-rays allow 
the initial recognition of the character of infection chang-
es and at the same time defining of probability regarding 
occurence of the etiological factors. The important anoma-
lies include: 
•	 	congested	and	pulpy	lungs	as a result of bronchopneu-
monia or pneumonia lobaris (bacterial infection),
•	 	lungs	 with	 reticular	 pattern	 indicating infectious 
interstitial pneumonia (virus or pneumocystis),
•	 	pleural	 fluid	 (it does not appear in pneumocystis how-
ever, frequent in gram-negative bacterial infections),
•	 	lung	 cavitation	 (gram-negative bacteria, TB, aspergil-
losis) [6].
The test that finally verifies pneumonia etiology is the 
microbiological one of the materials collected from the 
patient. In 76% of cases thanks to this test it is possible to 
identify the pathogen [7]. The patients after transplantation 
– apart from sputum and blood tests – undergo bronchosco-
py with BALF collection and optional bronchoscope lung’s 
biopsy [7,8]. Unfortunately, the result is obtained after a 
few weeks [8]. Clinical data that can help in narrowing 
of the diagnosis are identification of immunosuppressive 
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medicines and the time which passed since organ trans-
plantation. The basic immunosuppressive medicines are 
as follows: glicocorticosteroids, cyclosporine A and similar 
to some extent in mechanism of functioning are: tacroli-
mus, sirolimus, azathioprine and mofetil mycophynolate 
[9]. Each of the above mentioned medicines has different 
mechanism of functioning and as a result, their influence 
on non-specific immunity and humoral response (against 
microorganisms, especially bacteria) and viruses, fungi 
and some bacteria developing intrecellularly) is varying 
[9]. Table 1 presents types of immunity defected as a result 
of the most frequently applied medicines with the patho-
gene types which develop easily when they are used. The 
time that passed from transplantation to the first symp-
toms of pneumonia is relevant as it helps to identify the 
etiology of infection.(Table 2). During the first month after 
the transplantation, the dominating infections are those of 
etiology similar to the ones in immunocompetent patients 
after surgeries in the chest and abdominal cavity area, 
which is aspiration pneumonia caused by the bacteria pre-
sent in mouth cavity and bacterial infections [3]. Within 
1-6 months virus infections prevail (mainly cytomegalo-
virus) and fungal (the most frequent etiology: Aspergillus 
and Pneumocystis, less frequently: Cryptococcus, Candida); 
that time also TB pneumonia may occur [3]. Pneumonia 
morbidity among patinets with transplanted organs 
decreases after approx. one year from transplantation and 
etiology is close to those present among patients with nor-
mal immunity [3].
Patients with the suspicion of pneumonia and non-specific 
X-rays imaging of lung pulp and/or lack of response to the 
standard antibiotic treatment, undergo chest CT [6]. The 
medical tests protocol should include high definition imag-
es which allow detailed evaluation of changes morphology 
in lungs parenchyma. The CT imaging is not always char-
acteristic however, it is possible to identify some typical 
symptoms which are recognized in case of specific patho-
gens. The aim of this article is to present the most typi-
cal radiological symptoms which in the relevant clinical 




In patients after liver and kidney transplantation gram-
negative bacteria are resposible for 90% and 69% of 
bacterial pneumonia respectively [5,10]. The group of gram-
negative bacteria among others includes: Pseudomonas, 
Klebsiella, Eschericha, Acinetobacter and Enterobacter. 
Diversified radiological pneumonia imaging reflects this 
group’s complexity: starting with well separated nodules 
to the complex multifocal congestions with air broncho-
gram. The most frequent is this group is Pseudomonas aer-
uginosa responsible for approx. 60% of infections [5]. The 
infection with Pseudomonas takes place mainly as a result 
of aspiration in the upper airways and rarely through the 
blood stream regarding bacteremia. That is why, infection 
changes have the character of bronchopneumonia [11]. 
Radiological imaging presents dominating on both sides 
complex nodules with lower lobes predilection [12]. The 
changes in the lung parenchyma are very often accompa-
nied by pleural effusion or pleural thickening. With the 
development of the disease, the nodules conglomerate and 
form complex lung parenchyma with air bronchogram [12] 
(Figure 1). In Pseudomonas infection absces in lung par-
ynchema often occur. They are visible in the chest X-rays 
and have the form of circle infectious infiltrations with 
the bright interval meaning destruction of lung tissue [12]. 
Central bright interval may transform into a cavity with 
thick walls and liquid inside. Another gram-negative bacte-
ria very often causing pneumonia among transplant recipi-
ents is Klebsiella pneumoniae. It is responsible for lobe 
pneumonia similar in symptoms to pneumoccocus infection 
however, in case of Klebisiella, the infected lobe has bigger 
size which results in higher visibility of the interlobe spaces 
[13] (Figure 2). Absceses and effusions in the peural cavity 
occur more often than in pneumoccocus pneumonia [13].
Immunosuppresive medicines Type of defective immunity Type of pathogens
Corticosteroids Specific and non-specific immunity Intra- and extracellular 
Azathioprine
Mycophenolate mophetil







Table 1. Influence of immunosuppressive drugs on patients’ immunity and susceptibility to different microorganisms.
Time from transplantation Infections etiology among the transplantation recipients







As in the overall population
(In patients with the regular 
transplant function)
Table 2.  Etiology of pneumonia depending on the time from 
transplantation to the onset of infection.
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Figure 1.  Pneumonia with Pseudomonas aeruginosa etiology. The 
high definition CT shows complex consolidated infectious 
infiltrations in 6 segments of both lungs and in the upper 
right lobe. Additinally, there are spread nodules congestions 
with mid-lobule and bronchi distribution and bronchail 
congestion in the 3rd segment of the left lung.
A
Figure 2.  Pneumonia with Klebsiella pneumonice etiology. The high 
definition CT shows unified parenchyma congestions with 
air bronchogram located in the bottom lobe of the left lung 




MTBs are respnsible for approx. 2% to 5% of pneumonia 
cases among patients with lungs and heart transplants and 
for approx.20% of pneumonia cases among kidneys’ recipi-
ents [5,14,15]. The patients undergoing long-term immu-
nosuppression have increased risk of reactivation of dis-
eases they had before. They are also prone to the initial 
infection. The radiological imaging of TB among patients 
after transplantation is not characteristic. The spectrum of 
changes is very wide and includes separate nodules in lung 
parenchyma, complex nodules, complex lobe parenchyma 
changes, fibrocavitary changes in the upper parts of lungs, 
enlargement of lymph glands in mediastinum and effusion 
in pleural cavity [16] (Figure 3A, B). The only change that 
statistically more often occurs in lungs’ TB than in other 
bacterial infections is tree-in bud symptom [17] (Figure 3C). 
It is visible in high definition CT and results from the infec-
tious effusion of bronchial walls. It occurs in active TB and 
patient’s contagiousness. In patients treated with small 
doses of immunusuppresive medicines, the radiological 
imaging may be similar to the initial TB of patients with 
normal immunity so the congestions may appear in the 
upper and back part of the upper lobe or the upper part 
of the bottom lobe with the possibility of cavity develop-
ment [18]. The deeper immunosuppresion, the more fre-
quent lobe’s parenchyma congestions (caseous pneumonia), 
miliary changes taking form of small nodules (TB spread 
through the blood) and enlargement of the lymph glands of 
mediastinum and spaces in lungs including central necro-
sis and increased contrast [18] (Figure 3D). Evaluation of 
the activity regarding TB changes is a frequent clinical 
question. The changes indicating activity of the disease 
are parenchyma congestions, tree-in bud symptom, mil-
iary changes and cavities [16]. Linear congestions, calcified 
nodules and bronchiectasia are inactive modifications [16] 
(Table 3). However, the evaluation of the disease’s activity 
should be based on the conducted tests and stated lack of 




Cytomegalovirus pneumonia is a frequent complica-
tion during the first 6 months after transplantation. 
Cytomegalovirus is responsible for approx. 56% of lung 
infections among patients with transplanted lungs and 
47% of pneumonia in patients after liver transplantations 
[10,14]. Pneumonia caused by CMV can occur in approx. 2% 
of kidneys’ recipients [5]. High definition chest CT shows 
small spread nodule places located in the central part of 
lobule and the shading areas of ‘dim glass’ which in case of 
some patients may develop in the direction of parenchyma 
Review Article
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congestions [19] (Figure 4). Rather rarely the alveolar con-
gestions constitute initial changes. Thickening of the bron-
chial walls or a tree-in bud symptom occur rather rarely 
[19].
Flu virus (Influenzavirus)
Flu wirus is a frequent cause of the upper air pas-
sages infections among immunocompetent persons. 
In patients udergoing immunosuppresive treatment it 
also may cause pneumonia. However, it is not the only 
pathogen responsible for the lungs infection as very often 
the etiology is rather mixed. Microorganisms which are 
most frequently isolated from the patients after lungs 
Figure 3.  TB pneumonia. The chest imaging P-A shows a cavity with thick walls in the upper part of the right lung with the parenchyma congestions 
and bronchial thickening in the central and bottom part of the right lung (A). The high definition CT of this patient shows cavity with thick 
walls including aspergilloma in the upper part of the right lung, there is also thickening of pleura on its level and alveolar congestions in 
the surrounding parenchyma (B). There are also spread tree-in bud changes in the parenchyma of the right lung (C). CT of another patient 




Active TB Inactive TB







Table 3. HRCT features suggesting active vs. inactive tuberculosis.
Figure 4.  Pneumonia with CMV etiology. The high definition CT shows 
numerous but not well visible mid-lobule nodules.
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transplantations together with the flu virus are CMV and 
Pseudomonas aeruginosa [20] (Figure 5). Due to the over-
lapping of changes caused by different infectious factors in 
the radiological imaging, it is difficult to define character-
istic features of flu pneumonia. In most of the cases with 
the microbiologically confirmed pneumonia flu etiology, the 
chest X-rays present spread bilateral parenchyma conges-
tions and small not well separated nodules [21]. High defi-
nition chest CTs of these patients present shadings taking 
form of ‘dim glass’ with the nodules of 2–9 mm located in 
the central part of lobule, minor areas of alveolar conges-
tions and a tree-in bud symptom [21] (Figure 5).
Fungal infections
Aspergillus
Aspergillus is isolated in approx. 13% of patients with pul-
monary infections after lungs transplantations, 12% after 
heart transplantations, 9% after kidney transplantations 
and 3% after liver transplantations [5,10,14,15]. Aspergillus 
in the pulmonary area is responsible for a few diseases 
which develop depending on the immunological condi-
tions of the patients. In patients with the normal immu-
nity, it can cause saprophagan aspergilosis – aspergilloma 
or allergic broncho-pulmonary aspergillosis (ABPA) [22]. 
The patients with minor defects of immunity suffer from 
necrotic aspergillosis (half-invasive) [22]. Invasive aspergil-
losis – the form overtaking vessels, bronchi and the lungs 
parenchyma concerns patients with the serious immunity 
decrease. The invasive form of aspergillosis with infected 
bronchi and lungs parenchyma visible in CT includes domi-
nating spread mid-lobule nodules which together with 
the line shading constitute a tree-in bud image[22]. They 
are accompanied by the bronchial parenchyma conges-
tions and thickening of bronchial walls. The angi-invasive 
form concerns only patients with a seriuos defections of 
immunity i.e. patients undergoing treatments with the 
high amount of immunosuppresive medicines. The most 
characteristic change of this form of aspergillosis is halo 
sign present at the first stage of the disease even in 96% of 
patients [23] (Figure 6A). This symptom visible in CT refel-
cts blocking of small vessels by fungus and microcollaps-
es in the lungs parenchyma. This symptom also includes 
nodules and masses surrounded by the ‘dim glass’ shad-
ings. The nodules present places of collapsing and shad-
ings reflect alveloar bleeding. Although the symptom is 
also described in other diseases (among others in Wegener’s 
Granulomatosis, shifts of multivessel tumours, lung form 
of Kaposi tumour or infection of other etiology) in patients 
with infections resistant to the standard antibiotic thera-
py, it is considered to constitute the initial stage of angio-
invasive aspergillosis [23]. When the patient’s immunity 
improves (decrease of immunosuppressive medicnes doses) 
and implementation of antifungal treatment, the separation 
Figure 5.  Pneumonia with the mixed etiology: flu and Pseudomonas 
aeruginosa. The high definition CT shows spread areas of 
the ‘dim glass’, alveolar congestions and individual nodules 
forming an image of the tree-in bud.
Figure 6.  Angio-invasive form of aspergillosis. The high definition 
CT shows in the bottom left lung parenchyma congestions 
surrounded by the edging of the ‘dim glass’ – halo sign (A). 
The high definition CT of another patient during the period 
of the clinical improvement showed nodules surrounded by 
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Etiology Changes in HRCT
Pseudomonas aeruginosa Nodules in the lower lung lobes, 
absceses
Klebsiella pneumioniae Lobes congestions with air 
bronchogram, increased size of 
the infected lobe, visible inter-
lobe spaces
Mycobacterium tuberculosis Tree-in bud symptom
Changed imaging: from fibro-
cavitary changes in the upper 
parts of the lung to lobes 
congestions and miliary 
changes
CMV Nodules and ‘dim glass’ areas
Flu virus Nodules, ‘dim glass’ areas, tree-
in bud symptom
Table 4.  Radiologic manifestation of bacterial and viral pneumonia 
in HRCT.
of necrotic part of the lung from the surrounding parenchy-
ma takes place and in the radiological imaging it is shown 
as air edging (Figure 6B) [24].
Pneumocystis jiroveci (archaic: carinii)
Pneumocystis pneumonia occurs in 13% of patients after 
lungs transplantation, 6% after liver transplantation and 
4% after kidney transplantation [5,10,14]. The chest imag-
ing typically shows in this case bilateral internal linear 
changes in parenchyma which within a few days undergo 
development to alveolar congestions [25], (Figure 7A). In 
10–39% of patients the chest imaging may be correct and 
in another 5% the radiological imaging may be different 
and may include: isolated area of parenchyma congestions 
(mainly in upper lobes), spread nodules and cystic changes 
[25]. X-rays of 6% of patients show edema. In the high defi-
nition chest CT one can notice dominating bilateral internal 
shadings so-called ‘dim glass’ (present in 90% of patients 
[25]. 33% of patients have visible cystic changes in lung 
parenchyma, predilections to the upper lung lobes (Figure 
7B). Cystic changes with thin or thick walls have tendency 
to consolidating and if their location is underpleural, they 
constitute a risk of edema [25]. Edema fluid and enlarge-
ment of the mediastinum lymph glands occur very rarely in 
case of pneumocystic pneumonia and should suggest other 
disease recognitions
Candida albicans
Candida albicans is another blastomyces responsible for 
pneumonia in patients undergoing immunosuppression. It 
is most frequently isolated in patients after lungs trans-
plantation, as it colonizes necrotic areas of lungs paren-
chyma [26]. The changes visible in the chest imaging are 
non-specific and include segmental or lobe parenchyma 
congestions [26]. The high definition chest CT shows in 
Figure 7.  Pneumocystosis pneumonia (PCP). The chest imaging A-P 
of the intubated patient presents bilateral linear changes in 
central parenchyma (A). The high definition CT of this patient 
shows massive spread gruond-glass attenuation located 
in both lungs and minor cystic changes – pneumatocele – 
mainly in the upper lobes of both lungs (B).
A
B
Figure 8.  Pulmonary candidiasis pneumonia. The high definition CT 
shows numerous minor, well-separated nodules in both 
lower lung lobes.
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Etiology Changes in HRCT
Aspergillosis with changes in 
bronchi and lung parenchyma
Tree-in bud symptom, 
parenchyma and bronchit 
congestion, thickening of 
bronchial walls
Angio-invasive aspergillosis Halo sign, air edging
Pneumocystis jiroveci ‘Dim glass’ areas, cystic changes
Candida albicans Nodules in the lower lung lobes, 
parenchyma congestions, areas 
of the ‘dim glass’
Table 5. Radiologic manifestations of fungal pneumonia in HRCT.
most of the cases bilateral, well separated nodules mainly 
in the lower lung lobes [26] [Figure 8]. They may also be 
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accompanied by other changes: mainly parenchyma con-
gestions and shadings, less frequent are tree-in bud symp-
tom and thickening of bronchial walls [26]. Rarely in the 
cases of lungs cadidiasis halo sign or nodules occur.
Conclusions
The Tables 4 and 5 present changes visible in high defini-
tion chest CT of the patients with pneumonia after trns-
plantations. Unfortunately, only in some cases the radio-
logical imaging is so characteristic that it suggests etiol-
ogy of the lungs infection – it mainly concerns changes in 
Pneumocystis jiroveci infections and angio-invasive asper-
gillosis. The changes observed in pneumonia cases with 
different etiology are less characteristic however, together 
with clinical data regarding medical treatment and the 
time of infection occurence they may constitute basis for 
implementation of more specific treatment while waiting 
for the inoculation results.
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